Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders

D Li, S Yu, Y Long, A Shi, J Deng, Y Ma, J Wen… - Frontiers in …, 2022 - frontiersin.org
Neurological and psychiatric disorders are a category of chronic diseases that are
widespread and pose serious mental and physical health problems for patients. The …

An emerging cross-species marker for organismal health: tryptophan-kynurenine pathway

L Jamshed, A Debnath, S Jamshed, JV Wish… - International Journal of …, 2022 - mdpi.com
Tryptophan (TRP) is an essential dietary amino acid that, unless otherwise committed to
protein synthesis, undergoes metabolism via the Tryptophan-Kynurenine (TRP-KYN) …

Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta …

M Fathi, K Vakili, S Yaghoobpoor, A Tavasol… - Frontiers in …, 2022 - frontiersin.org
Background Tryptophan (TRP) is an essential amino acid that must be provided in the diet.
The kynurenine pathway (KP) is the main route of TRP catabolism into nicotinamide …

Transition metal ions and neurotransmitters: coordination chemistry and implications for neurodegeneration

J Yoo, J Han, MH Lim - RSC Chemical Biology, 2023 - pubs.rsc.org
Neurodegeneration is characterized by a disturbance in neurotransmitter-mediated
signaling pathways. Recent studies have highlighted the significant role of transition metal …

Research progress on the kynurenine pathway in the prevention and treatment of Parkinson's disease

P Chen, X Geng - Journal of Enzyme Inhibition and Medicinal …, 2023 - Taylor & Francis
Parkinson's disease (PD) is characterised by progressive death of dopamine (DA) neurons
in the substantia nigra pars compacta (SNpc) and pathological accumulation of α-synuclein …

The chronic unpredictable mild stress (CUMS) Paradigm: Bridging the gap in depression research from bench to bedside

S Sharma, S Chawla, P Kumar, R Ahmad, PK Verma - Brain Research, 2024 - Elsevier
Depression is a complicated neuropsychiatric condition with an incompletely understood
etiology, making the discovery of effective therapies challenging. Animal models have been …

Kynurenine‐3‐monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression

Y Chen, J Zhang, Y Yang, K Xiang, H Li… - Journal of Cellular …, 2022 - Wiley Online Library
Abstract Kynurenine‐3‐monooxygenase (KMO) is a mitochondrial enzyme involved in the
eukaryotic kynurenine pathway (KP), which is the major catabolic route of tryptophan. KMO …

[HTML][HTML] Thinking outside the brain: gut microbiome influence on innate immunity within neurodegenerative disease

AR Merchak, MKL Bolen, MG Tansey, KB Menees - Neurotherapeutics, 2024 - Elsevier
The complex network of factors that contribute to neurodegeneration have hampered the
discovery of effective preventative measures. While much work has focused on brain-first …

Samarium-based turn-off fluorescence sensor for sensitive and selective detection of quinolinic acid in human urine and serum

BD Zhang, B Liu, YX Yin, L Xu - Inorganic Chemistry, 2022 - ACS Publications
Quinolinic acid (QA) is an index for some diseases, whose detection is of importance. This
work presents a samarium metal–organic framework (Sm-MOF) containing 5 …

[HTML][HTML] In-silico screening and ADMET evaluation of therapeutic MAO-B inhibitors against Parkinson disease

A Ajala, WA Eltayb, TM Abatyough, S Ejeh, HA Otaru… - Intelligent …, 2024 - Elsevier
MAOs are flavoenzymes that aid in the oxidative deamination of neurotransmitters such as
dopamine, serotonin, and epinephrine. MAO inhibitors are antidepressants that act by …